Panagora Asset Management Inc Zai Lab LTD Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $67,360 - $144,618	-2,911 Reduced 24.41%	9,013 $313,000
Q4 2021 Feb 10, 2022	BUY	$54.9 - $105.21 $120,395 - $230,725	2,193 Added 22.54%	11,924 $749,000
Q3 2021 Nov 10, 2021	SELL	$105.0 - $178.37 $35,700 - $60,645	-340 Reduced 3.38%	9,731 $1.03 Million
Q2 2021 Aug 11, 2021	SELL	$125.11 - $180.0 $25,522 - $36,720	-204 Reduced 1.99%	10,071 $1.78 Million
Q1 2021 May 12, 2021	BUY	$126.27 - $191.71 $465,431 - $706,643	3,686 Added 55.94%	10,275 $1.37 Million
Q4 2020 Feb 10, 2021	BUY	$81.94 - $135.34 $113,732 - $187,851	1,388 Added 26.69%	6,589 $892,000
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $106,065 - $129,477	1,447 Added 38.55%	5,201 $432,000
Q2 2020 Aug 12, 2020	BUY	$48.82 - $82.53 $126,248 - $213,422	2,586 Added 221.4%	3,754 $308,000
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $45,668 - $73,467	1,168 New	1,168 $60,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.